Literature DB >> 25064406

Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.

Li Chen1, Wen Ming Xu2, Dan Zhang1.   

Abstract

OBJECTIVE: To study the expression of insulin signaling-related genes and oxidative stress markers in the visceral adipose tissue obtained from polycystic ovary syndrome (PCOS) patients and healthy control subjects and to investigate the relationships among abdominal obesity, insulin resistance, and oxidative stress at the tissue level.
DESIGN: Case-control study.
SETTING: University teaching hospital. PATIENT(S): In total, 30 PCOS patients and 30 healthy control subjects, who underwent laparoscopic surgery, were included in the study. INTERVENTION(S): Abdominal obesity was defined based on waist circumference (WC). The homeostasis model index was used to assess insulin resistance (HOMA-IR). MAIN OUTCOME MEASURE(S): Gene expression of glucose transporter 4 (GLUT4) and insulin receptor substrate 1 (IRS1) in visceral adipose tissue (VAT) and the parameters of oxidative stress, such as superoxide dismutase, enzyme glutathione reductase, and dimethylarginine, were measured, and the expression of protein oxidative damage product 3-nitro-tyrosine residues (nitrotyrosine) in VAT was identified with the use of immunohistochemistry. RESULT(S): PCOS was associated with lower expression of GLUT4 and IRS1 and a higher level of oxidative stress in VAT, which was strongly correlated with WC and HOMA-IR. Presence of abdominal obesity further intensified the correlations observed in our measurements. The nitrotyrosine expression in VAT was stronger in PCOS patients. CONCLUSION(S): The strong correlation of insulin resistance with oxidative stress at the VAT level suggests that local oxidative stress and abnormalities of insulin signaling in adipose tissue play critical roles in the pathogenesis of PCOS.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Polycystic ovary syndrome (PCOS); abdominal obesity; insulin resistance; oxidative stress; visceral adipose tissue (VAT); waist circumference (WC)

Mesh:

Substances:

Year:  2014        PMID: 25064406     DOI: 10.1016/j.fertnstert.2014.06.027

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.

Authors:  Zehra Kucukaydın; Cevdet Duran; Mustafa Basaran; Fatos Camlica; Sami Said Erdem; Ahmet Basaran; Orkide Kutlu; Ferda Sevimli Burnik; Halis Elmas; Mustafa Sait Gonen
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

2.  Effects of insulin resistance on myometrial growth.

Authors:  Zhi-Min Hou; Qian Sun; Yan-Zhi Liu; Tie-Fu Chen; Na Tang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Mediators of Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.

Authors:  Muraly Puttabyatappa; Victoria Andriessen; Makeda Mesquitta; Lixia Zeng; Subramaniam Pennathur; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

4.  The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.

Authors:  M A Yilmaz; C Duran; M Basaran
Journal:  J Endocrinol Invest       Date:  2015-06-23       Impact factor: 4.256

5.  Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome.

Authors:  Cevdet Duran; Mustafa Basaran; Orkide Kutlu; Zehra Kucukaydin; Suleyman Bakdik; Ferda Sevimli Burnik; Uysaler Aslan; Sami Said Erdem; Samil Ecirli
Journal:  Endocrine       Date:  2014-12-19       Impact factor: 3.633

Review 6.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-09       Impact factor: 5.187

7.  THE EFFECT OF MYOINOSITOL AND METFORMIN ON CARDIOVASCULAR RISK FACTORS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: A RANDOMIZED CONTROLLED TRIAL.

Authors:  V Soldat-Stankovic; S Popovic Pejicic; S Stankovic; J Jovanic; J Bjekic-Macut; S Livadas; S Ognjanovic; G Mastorakos; D Micic; D Macut
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

8.  Peroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects.

Authors:  Sheng Zhang; Yafeng Wang; Heping Jiang; Chao Liu; Bin Sun; Shuchen Chen; Mingqiang Kang; Weifeng Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Insulin receptor substrate-1 (IRS-1) rs1801278G>A polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis.

Authors:  Weifeng Tang; Yafeng Wang; Heping Jiang; Chao Liu; Changqing Dong; Shuchen Chen; Mingqiang Kang; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Correlation Between Daily Energy Intake from Fat with Insulin Resistance in Patients with Polycystic Ovary Syndrome.

Authors:  Xin Zheng; Yun Chen; Danyan Ma; Mulin Zhang; Yinxiang Huang; Meifeng Tong; Bing Yan; Shaowei Lin; Xiaohong Yan; Changqin Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-22       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.